APRI Apricus Biosciences Inc.

1.75
-0.02  -1%
Previous Close 1.77
Open 1.79
Price To book 3.43
Market Cap 22371582
Shares 12,783,761
Volume 199,620
Short Ratio 3.80
Av. Daily Volume 454,961

SEC filingsSee all SEC filings

  1. 8-K - Current report 171079504
  2. 8-K - Current report 171061834
  3. S-3 - Registration statement under Securities Act of 1933 171043795
  4. 8-K - Current report 17999956
  5. 10-Q - Quarterly report [Sections 13 or 15(d)] 17999894

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

PDUFA date for NDA resubmission February 17, 2018.
Vitaros
Erectile dysfunction
Phase 2b planned - seeking partnership.
RayVa
Secondary Raynaud's Phenomenon